Submit Search
Upload
How to Make Safe & Effective OTC Consumer Health Products
•
1 like
•
721 views
S
scoopnewsgroup
Follow
Kathy Hibbs, Chief Legal & Regulatory Officer, 23andMe 2019 FedTalks
Read less
Read more
Government & Nonprofit
Report
Share
Report
Share
1 of 40
Download now
Download to read offline
Recommended
CNA Diagnostics Info Slide Deck.November2016 (2016_12_03 06_09_43 UTC)
CNA Diagnostics Info Slide Deck.November2016 (2016_12_03 06_09_43 UTC)
Greg Andrews DVM
Virios Therapeutics Investor Deck March 2021
Virios Therapeutics Investor Deck March 2021
RedChip Companies, Inc.
Greenwich LifeSciences (GLSI) January 2021
Greenwich LifeSciences (GLSI) January 2021
RedChip Companies, Inc.
Investor Present 04202017
Investor Present 04202017
RedChip Companies, Inc.
Ir presentation 062314
Ir presentation 062314
RedChip Companies, Inc.
Exact Sciences 2015 J.P Morgan Healthcare Conference Presentation
Exact Sciences 2015 J.P Morgan Healthcare Conference Presentation
Exact Sciences
Virios Therapeutics Presentation Q3 2021
Virios Therapeutics Presentation Q3 2021
RedChip Companies, Inc.
BioVie Investor Deck, October 2021
BioVie Investor Deck, October 2021
RedChip Companies, Inc.
Recommended
CNA Diagnostics Info Slide Deck.November2016 (2016_12_03 06_09_43 UTC)
CNA Diagnostics Info Slide Deck.November2016 (2016_12_03 06_09_43 UTC)
Greg Andrews DVM
Virios Therapeutics Investor Deck March 2021
Virios Therapeutics Investor Deck March 2021
RedChip Companies, Inc.
Greenwich LifeSciences (GLSI) January 2021
Greenwich LifeSciences (GLSI) January 2021
RedChip Companies, Inc.
Investor Present 04202017
Investor Present 04202017
RedChip Companies, Inc.
Ir presentation 062314
Ir presentation 062314
RedChip Companies, Inc.
Exact Sciences 2015 J.P Morgan Healthcare Conference Presentation
Exact Sciences 2015 J.P Morgan Healthcare Conference Presentation
Exact Sciences
Virios Therapeutics Presentation Q3 2021
Virios Therapeutics Presentation Q3 2021
RedChip Companies, Inc.
BioVie Investor Deck, October 2021
BioVie Investor Deck, October 2021
RedChip Companies, Inc.
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences
Virios Therapeutics Presentation
Virios Therapeutics Presentation
RedChip Companies, Inc.
May 2016 Corporate Presentation
May 2016 Corporate Presentation
Exact Sciences
Third-Quarter 2015 Earnings Call Slides
Third-Quarter 2015 Earnings Call Slides
Exact Sciences
Exact Sciences Corporate Presentation: April 2016
Exact Sciences Corporate Presentation: April 2016
Exact Sciences
Exas october 2016 corporate presentation
Exas october 2016 corporate presentation
Exact Sciences
Greenwich LifeSciences (GLSI) November 2021
Greenwich LifeSciences (GLSI) November 2021
RedChip Companies, Inc.
Trends in Gene Therapy - Report Extract
Trends in Gene Therapy - Report Extract
Pharma Intelligence
BiondVax presentation q4 2017
BiondVax presentation q4 2017
BiondVax Pharmaceuticals Ltd.
June 2016 Corporate Presentation
June 2016 Corporate Presentation
Sam Zastrow
1 q18 corporate presentation
1 q18 corporate presentation
Exact Sciences
Reviva Pharmaceuticals Holdings Presentation September 2021
Reviva Pharmaceuticals Holdings Presentation September 2021
RedChip Companies, Inc.
BiondVax 8 page brochure
BiondVax 8 page brochure
BiondVax Pharmaceuticals Ltd.
Exact Sciences December 2015 Corporate Presentation
Exact Sciences December 2015 Corporate Presentation
Exact Sciences
2016 J.P. Morgan Health Care Conference
2016 J.P. Morgan Health Care Conference
Exact Sciences
Genetic Technologies Presentation - January 2021
Genetic Technologies Presentation - January 2021
RedChip Companies, Inc.
Gene Presentation October 2019
Gene Presentation October 2019
RedChip Companies, Inc.
AI in healthcare - SF Bay ACM chapter
AI in healthcare - SF Bay ACM chapter
Alex Ermolaev
Genetic technologies Investor Presentation
Genetic technologies Investor Presentation
RedChip Companies, Inc.
Genetic Technologies Investor Presentation September 2022
Genetic Technologies Investor Presentation September 2022
RedChip Companies, Inc.
09 CeoMeeting- Session 4- Medicines for Malaria
09 CeoMeeting- Session 4- Medicines for Malaria
MLSCF
Diagnos Inc. Investor Presentation September 2018
Diagnos Inc. Investor Presentation September 2018
MomentumPR
More Related Content
What's hot
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences
Virios Therapeutics Presentation
Virios Therapeutics Presentation
RedChip Companies, Inc.
May 2016 Corporate Presentation
May 2016 Corporate Presentation
Exact Sciences
Third-Quarter 2015 Earnings Call Slides
Third-Quarter 2015 Earnings Call Slides
Exact Sciences
Exact Sciences Corporate Presentation: April 2016
Exact Sciences Corporate Presentation: April 2016
Exact Sciences
Exas october 2016 corporate presentation
Exas october 2016 corporate presentation
Exact Sciences
Greenwich LifeSciences (GLSI) November 2021
Greenwich LifeSciences (GLSI) November 2021
RedChip Companies, Inc.
Trends in Gene Therapy - Report Extract
Trends in Gene Therapy - Report Extract
Pharma Intelligence
BiondVax presentation q4 2017
BiondVax presentation q4 2017
BiondVax Pharmaceuticals Ltd.
June 2016 Corporate Presentation
June 2016 Corporate Presentation
Sam Zastrow
1 q18 corporate presentation
1 q18 corporate presentation
Exact Sciences
Reviva Pharmaceuticals Holdings Presentation September 2021
Reviva Pharmaceuticals Holdings Presentation September 2021
RedChip Companies, Inc.
BiondVax 8 page brochure
BiondVax 8 page brochure
BiondVax Pharmaceuticals Ltd.
Exact Sciences December 2015 Corporate Presentation
Exact Sciences December 2015 Corporate Presentation
Exact Sciences
2016 J.P. Morgan Health Care Conference
2016 J.P. Morgan Health Care Conference
Exact Sciences
What's hot
(15)
Exact Sciences Company Presentation Baird Healthcare Conference
Exact Sciences Company Presentation Baird Healthcare Conference
Virios Therapeutics Presentation
Virios Therapeutics Presentation
May 2016 Corporate Presentation
May 2016 Corporate Presentation
Third-Quarter 2015 Earnings Call Slides
Third-Quarter 2015 Earnings Call Slides
Exact Sciences Corporate Presentation: April 2016
Exact Sciences Corporate Presentation: April 2016
Exas october 2016 corporate presentation
Exas october 2016 corporate presentation
Greenwich LifeSciences (GLSI) November 2021
Greenwich LifeSciences (GLSI) November 2021
Trends in Gene Therapy - Report Extract
Trends in Gene Therapy - Report Extract
BiondVax presentation q4 2017
BiondVax presentation q4 2017
June 2016 Corporate Presentation
June 2016 Corporate Presentation
1 q18 corporate presentation
1 q18 corporate presentation
Reviva Pharmaceuticals Holdings Presentation September 2021
Reviva Pharmaceuticals Holdings Presentation September 2021
BiondVax 8 page brochure
BiondVax 8 page brochure
Exact Sciences December 2015 Corporate Presentation
Exact Sciences December 2015 Corporate Presentation
2016 J.P. Morgan Health Care Conference
2016 J.P. Morgan Health Care Conference
Similar to How to Make Safe & Effective OTC Consumer Health Products
Genetic Technologies Presentation - January 2021
Genetic Technologies Presentation - January 2021
RedChip Companies, Inc.
Gene Presentation October 2019
Gene Presentation October 2019
RedChip Companies, Inc.
AI in healthcare - SF Bay ACM chapter
AI in healthcare - SF Bay ACM chapter
Alex Ermolaev
Genetic technologies Investor Presentation
Genetic technologies Investor Presentation
RedChip Companies, Inc.
Genetic Technologies Investor Presentation September 2022
Genetic Technologies Investor Presentation September 2022
RedChip Companies, Inc.
09 CeoMeeting- Session 4- Medicines for Malaria
09 CeoMeeting- Session 4- Medicines for Malaria
MLSCF
Diagnos Inc. Investor Presentation September 2018
Diagnos Inc. Investor Presentation September 2018
MomentumPR
Pharmaceuticals 3.0
Pharmaceuticals 3.0
Harshit Jain
Genetic Technologies Biotech Showcase Presentation
Genetic Technologies Biotech Showcase Presentation
RedChip Companies, Inc.
Genetic Technologies Biotech Showcase Presentation - w/COVID
Genetic Technologies Biotech Showcase Presentation - w/COVID
RedChip Companies, Inc.
Minimal Residual Disease Testing Market.pptx
Minimal Residual Disease Testing Market.pptx
Aryan Mishra
Interpace Diagnostics Investor Presentation
Interpace Diagnostics Investor Presentation
RedChip Companies, Inc.
What the Shift to Value Means for Pharmaceuticals
What the Shift to Value Means for Pharmaceuticals
Medullan
Gardenburger
Gardenburger
aakaw
Risk averse pitch deck
Risk averse pitch deck
MichaelLloyd29
Smoking and lung cancer and now Covid
Smoking and lung cancer and now Covid
Robert J Miller MD
GENE Presentation
GENE Presentation
RedChip Companies, Inc.
GENE Investor Deck May 2023
GENE Investor Deck May 2023
RedChip Companies, Inc.
BetterCells Investor Presentation
BetterCells Investor Presentation
Andrew Haythorpe
Savvy grey presentation v3
Savvy grey presentation v3
rickgmann
Similar to How to Make Safe & Effective OTC Consumer Health Products
(20)
Genetic Technologies Presentation - January 2021
Genetic Technologies Presentation - January 2021
Gene Presentation October 2019
Gene Presentation October 2019
AI in healthcare - SF Bay ACM chapter
AI in healthcare - SF Bay ACM chapter
Genetic technologies Investor Presentation
Genetic technologies Investor Presentation
Genetic Technologies Investor Presentation September 2022
Genetic Technologies Investor Presentation September 2022
09 CeoMeeting- Session 4- Medicines for Malaria
09 CeoMeeting- Session 4- Medicines for Malaria
Diagnos Inc. Investor Presentation September 2018
Diagnos Inc. Investor Presentation September 2018
Pharmaceuticals 3.0
Pharmaceuticals 3.0
Genetic Technologies Biotech Showcase Presentation
Genetic Technologies Biotech Showcase Presentation
Genetic Technologies Biotech Showcase Presentation - w/COVID
Genetic Technologies Biotech Showcase Presentation - w/COVID
Minimal Residual Disease Testing Market.pptx
Minimal Residual Disease Testing Market.pptx
Interpace Diagnostics Investor Presentation
Interpace Diagnostics Investor Presentation
What the Shift to Value Means for Pharmaceuticals
What the Shift to Value Means for Pharmaceuticals
Gardenburger
Gardenburger
Risk averse pitch deck
Risk averse pitch deck
Smoking and lung cancer and now Covid
Smoking and lung cancer and now Covid
GENE Presentation
GENE Presentation
GENE Investor Deck May 2023
GENE Investor Deck May 2023
BetterCells Investor Presentation
BetterCells Investor Presentation
Savvy grey presentation v3
Savvy grey presentation v3
More from scoopnewsgroup
2020: What's on Deck for the PMA
2020: What's on Deck for the PMA
scoopnewsgroup
Modernization Requires Choice
Modernization Requires Choice
scoopnewsgroup
Smarter Access is the Bridge to Security Modernization
Smarter Access is the Bridge to Security Modernization
scoopnewsgroup
How Zero Trust Makes the Mission Simple & Secure
How Zero Trust Makes the Mission Simple & Secure
scoopnewsgroup
Building a Zero Trust Architecture
Building a Zero Trust Architecture
scoopnewsgroup
History of Data-Centric Transformation
History of Data-Centric Transformation
scoopnewsgroup
IC Fireside Chat
IC Fireside Chat
scoopnewsgroup
The Edge to AI
The Edge to AI
scoopnewsgroup
Data Strategy – What Does an Enterprise Data Cloud Mean for Your Agency?
Data Strategy – What Does an Enterprise Data Cloud Mean for Your Agency?
scoopnewsgroup
Devil's Bargain: Sacrificing Strategic Investments to Fund Today's Problems
Devil's Bargain: Sacrificing Strategic Investments to Fund Today's Problems
scoopnewsgroup
Moving Beyond Zero Trust
Moving Beyond Zero Trust
scoopnewsgroup
Keeping the Workforce of the Future Empowered, Engaged & Happy
Keeping the Workforce of the Future Empowered, Engaged & Happy
scoopnewsgroup
Opening Remarks
Opening Remarks
scoopnewsgroup
It All Starts with Linux
It All Starts with Linux
scoopnewsgroup
Leadership in the Digital Age
Leadership in the Digital Age
scoopnewsgroup
Digital Transformation for Government
Digital Transformation for Government
scoopnewsgroup
DevSecOps: The DoD Software Factory
DevSecOps: The DoD Software Factory
scoopnewsgroup
Enhancing your Cyber Skills through a Cyber Range
Enhancing your Cyber Skills through a Cyber Range
scoopnewsgroup
Lessons Learned from Fire Escapes for Cybersecurity
Lessons Learned from Fire Escapes for Cybersecurity
scoopnewsgroup
2019 FedScoop Public Sector innovation Summit
2019 FedScoop Public Sector innovation Summit
scoopnewsgroup
More from scoopnewsgroup
(20)
2020: What's on Deck for the PMA
2020: What's on Deck for the PMA
Modernization Requires Choice
Modernization Requires Choice
Smarter Access is the Bridge to Security Modernization
Smarter Access is the Bridge to Security Modernization
How Zero Trust Makes the Mission Simple & Secure
How Zero Trust Makes the Mission Simple & Secure
Building a Zero Trust Architecture
Building a Zero Trust Architecture
History of Data-Centric Transformation
History of Data-Centric Transformation
IC Fireside Chat
IC Fireside Chat
The Edge to AI
The Edge to AI
Data Strategy – What Does an Enterprise Data Cloud Mean for Your Agency?
Data Strategy – What Does an Enterprise Data Cloud Mean for Your Agency?
Devil's Bargain: Sacrificing Strategic Investments to Fund Today's Problems
Devil's Bargain: Sacrificing Strategic Investments to Fund Today's Problems
Moving Beyond Zero Trust
Moving Beyond Zero Trust
Keeping the Workforce of the Future Empowered, Engaged & Happy
Keeping the Workforce of the Future Empowered, Engaged & Happy
Opening Remarks
Opening Remarks
It All Starts with Linux
It All Starts with Linux
Leadership in the Digital Age
Leadership in the Digital Age
Digital Transformation for Government
Digital Transformation for Government
DevSecOps: The DoD Software Factory
DevSecOps: The DoD Software Factory
Enhancing your Cyber Skills through a Cyber Range
Enhancing your Cyber Skills through a Cyber Range
Lessons Learned from Fire Escapes for Cybersecurity
Lessons Learned from Fire Escapes for Cybersecurity
2019 FedScoop Public Sector innovation Summit
2019 FedScoop Public Sector innovation Summit
Recently uploaded
Akurdi ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready For S...
Akurdi ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready For S...
tanu pandey
Regional Snapshot Atlanta Aging Trends 2024
Regional Snapshot Atlanta Aging Trends 2024
ARCResearch
EDUROOT SME_ Performance upto March-2024.pptx
EDUROOT SME_ Performance upto March-2024.pptx
aaryamanorathofficia
Call Girls Service Connaught Place @9999965857 Delhi 🫦 No Advance VVIP 🍎 SER...
Call Girls Service Connaught Place @9999965857 Delhi 🫦 No Advance VVIP 🍎 SER...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
The Most Attractive Pune Call Girls Handewadi Road 8250192130 Will You Miss T...
The Most Attractive Pune Call Girls Handewadi Road 8250192130 Will You Miss T...
ranjana rawat
Lucknow 💋 Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8...
Lucknow 💋 Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8...
anilsa9823
Top Rated Pune Call Girls Bhosari ⟟ 6297143586 ⟟ Call Me For Genuine Sex Ser...
Top Rated Pune Call Girls Bhosari ⟟ 6297143586 ⟟ Call Me For Genuine Sex Ser...
Call Girls in Nagpur High Profile
Call Girls Sangamwadi Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Sangamwadi Call Me 7737669865 Budget Friendly No Advance Booking
roncy bisnoi
Election 2024 Presiding Duty Keypoints_01.pdf
Election 2024 Presiding Duty Keypoints_01.pdf
Samirsinh Parmar
Climate change and occupational safety and health.
Climate change and occupational safety and health.
Christina Parmionova
Just Call Vip call girls Wardha Escorts ☎️8617370543 Starting From 5K to 25K ...
Just Call Vip call girls Wardha Escorts ☎️8617370543 Starting From 5K to 25K ...
Dipal Arora
VIP Model Call Girls Kiwale ( Pune ) Call ON 8005736733 Starting From 5K to 2...
VIP Model Call Girls Kiwale ( Pune ) Call ON 8005736733 Starting From 5K to 2...
SUHANI PANDEY
2024 Zoom Reinstein Legacy Asbestos Webinar
2024 Zoom Reinstein Legacy Asbestos Webinar
Linda Reinstein
Incident Command System xxxxxxxxxxxxxxxxxxxxxxxxx
Incident Command System xxxxxxxxxxxxxxxxxxxxxxxxx
Peter Miles
Booking open Available Pune Call Girls Shukrawar Peth 6297143586 Call Hot In...
Booking open Available Pune Call Girls Shukrawar Peth 6297143586 Call Hot In...
tanu pandey
2024: The FAR, Federal Acquisition Regulations, Part 30
2024: The FAR, Federal Acquisition Regulations, Part 30
JSchaus & Associates
Call Girls Nanded City Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Nanded City Call Me 7737669865 Budget Friendly No Advance Booking
roncy bisnoi
Global debate on climate change and occupational safety and health.
Global debate on climate change and occupational safety and health.
Christina Parmionova
VIP Call Girls Bhavnagar 7001035870 Whatsapp Number, 24/07 Booking
VIP Call Girls Bhavnagar 7001035870 Whatsapp Number, 24/07 Booking
dharasingh5698
Postal Ballots-For home voting step by step process 2024.pptx
Postal Ballots-For home voting step by step process 2024.pptx
SwastiRanjanNayak
Recently uploaded
(20)
Akurdi ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready For S...
Akurdi ( Call Girls ) Pune 6297143586 Hot Model With Sexy Bhabi Ready For S...
Regional Snapshot Atlanta Aging Trends 2024
Regional Snapshot Atlanta Aging Trends 2024
EDUROOT SME_ Performance upto March-2024.pptx
EDUROOT SME_ Performance upto March-2024.pptx
Call Girls Service Connaught Place @9999965857 Delhi 🫦 No Advance VVIP 🍎 SER...
Call Girls Service Connaught Place @9999965857 Delhi 🫦 No Advance VVIP 🍎 SER...
The Most Attractive Pune Call Girls Handewadi Road 8250192130 Will You Miss T...
The Most Attractive Pune Call Girls Handewadi Road 8250192130 Will You Miss T...
Lucknow 💋 Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8...
Lucknow 💋 Russian Call Girls Lucknow ₹7.5k Pick Up & Drop With Cash Payment 8...
Top Rated Pune Call Girls Bhosari ⟟ 6297143586 ⟟ Call Me For Genuine Sex Ser...
Top Rated Pune Call Girls Bhosari ⟟ 6297143586 ⟟ Call Me For Genuine Sex Ser...
Call Girls Sangamwadi Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Sangamwadi Call Me 7737669865 Budget Friendly No Advance Booking
Election 2024 Presiding Duty Keypoints_01.pdf
Election 2024 Presiding Duty Keypoints_01.pdf
Climate change and occupational safety and health.
Climate change and occupational safety and health.
Just Call Vip call girls Wardha Escorts ☎️8617370543 Starting From 5K to 25K ...
Just Call Vip call girls Wardha Escorts ☎️8617370543 Starting From 5K to 25K ...
VIP Model Call Girls Kiwale ( Pune ) Call ON 8005736733 Starting From 5K to 2...
VIP Model Call Girls Kiwale ( Pune ) Call ON 8005736733 Starting From 5K to 2...
2024 Zoom Reinstein Legacy Asbestos Webinar
2024 Zoom Reinstein Legacy Asbestos Webinar
Incident Command System xxxxxxxxxxxxxxxxxxxxxxxxx
Incident Command System xxxxxxxxxxxxxxxxxxxxxxxxx
Booking open Available Pune Call Girls Shukrawar Peth 6297143586 Call Hot In...
Booking open Available Pune Call Girls Shukrawar Peth 6297143586 Call Hot In...
2024: The FAR, Federal Acquisition Regulations, Part 30
2024: The FAR, Federal Acquisition Regulations, Part 30
Call Girls Nanded City Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Nanded City Call Me 7737669865 Budget Friendly No Advance Booking
Global debate on climate change and occupational safety and health.
Global debate on climate change and occupational safety and health.
VIP Call Girls Bhavnagar 7001035870 Whatsapp Number, 24/07 Booking
VIP Call Girls Bhavnagar 7001035870 Whatsapp Number, 24/07 Booking
Postal Ballots-For home voting step by step process 2024.pptx
Postal Ballots-For home voting step by step process 2024.pptx
How to Make Safe & Effective OTC Consumer Health Products
1.
Chief Legal &
Regulatory Officer, 23andMe @23andMe
2.
Empowering Consumers Through OTC
Products
3.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved Our mission is to help people access, understand and benefit from the human genome 44
4.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved Growth over 13 Years warning letter GHR authorization ~10M+ kits sold 2008 2010 2012 2014 2016 2018 BRCA authorization PGt authorization Carrier Status authorization 5 1M 10M MUTYH authorization 5
5.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved How It Works 6 Order/Buy Spit Send Discover 23andme.com | Amazon.com CVS | Target | Walgreens Walmart | Sam’s Club | Best Buy Just a few milliliters of saliva is needed Results are returned within 6-8 weeks to secure online account Saliva samples are processed in labs that meet local regulations 6
6.
7Copyright © 2019
23andMe, Inc. First and only DTC service with reports authorized by the FDA 40+ Carrier Status* 30+ Traits 8 Wellness 35+ Ancestry 10+ Health Predispositions* *The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child’s risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. For important information and limitations regarding other genetic health risk reports and carrier status reports, visit https://www.23andme.com/test-info
7.
8Copyright © 2019
23andMe, Inc. Sample Genetic Health Risk Report
8.
9Copyright © 2019
23andMe, Inc. Sample Wellness Report
9.
10Copyright © 2019
23andMe, Inc. Sample Trait Report
10.
11Copyright © 2019
23andMe, Inc. Sample Ancestry Report
11.
12Copyright © 2019
23andMe, Inc. Changing the Conversation about Race
12.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved 23andMe Research 13
13.
14Copyright © 2017
23andMe, Inc. All rights reserved. 130+ peer-reviewed papers 23andme.com/publications Diverse set of therapeutic programs in oncology, skin, respiratory, and cardiovascular disease UNDERSTAND TREAT Research Goals
14.
15Copyright © 2017
23andMe, Inc. All rights reserved. Copyright © 2017 23andMe, Inc. All rights reserved. From https://www.cdc.gov/about/report/chronic-disease- prevention.html PREVENT Research Goals
15.
16Copyright © 2019
23andMe, Inc. 10Mkits sold 90%don’t know they have it 80%of customers consent to participate in research 90%don’t know they have it 2Bsurvey questions answered Largest Recontactable Platform for Research
16.
17Copyright © 2019
23andMe, Inc. Data Collection Via Online Surveys
17.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved 130 + Peer-Reviewed Papers Published Since 2010 Full publication list available: https://www.23andme.com/publications/ 18 Psychiatric disorders Skin cancer Addiction Appendicitis Parkinson’s disease Cannabis use Sexual preference 18
18.
19Copyright © 2019
23andMe, Inc. Discoveries from Fun...
19.
20Copyright © 2019
23andMe, Inc. To Serious... 450,000 23andMe Consented Customers participated
20.
21Copyright © 2019
23andMe, Inc. Engaging Consumers in the Research Cycle Make discoveries Share discoveries with the consumer Consented, engaged consumers
21.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved Data Powers Reports 22
22.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved From Question to Analysis 23 Q. Does drinking a caffeinated beverage (tea, coffee, soda, or an energy drink) usually make you jittery, restless, or full of nervous energy? 23
23.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved Further Analysis 24 “Heavy caffeine drinkers:” cases report drinking several caffeinated drinks per day 24
24.
25Copyright © 2019
23andMe, Inc. 23andMe Report
25.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved Polygenic Risk Report Development 26
26.
27Copyright © 2019
23andMe, Inc. ● Most current genetic tests focus on a small number of rare variants of large effect. ● For common diseases, rare variants of large effect only account for a small proportion of the inherited likelihood of developing a condition. ○ Breast cancer (all panel genes account for ~25% of inherited risk) ● Much of the remaining inherited likelihood is explained by common variants. ● The variants are detected with a machine learning algorithm and the combined effect of the variants detected results in a polygenic score. Polygenic Score
27.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved Type 2 Diabetes Polygenic Score 28
28.
29Copyright © 2019
23andMe, Inc. 1 in 3Americans have prediabetes1 90%don’t know they have it 90%with prediabetes don’t know they have it 90%don’t know they have it $327Bestimated in healthcare costs annually2 Why Build a Type 2 Diabetes Report? 1. Centers for Disease Control and Prevention (CDC), Prediabetes: Your Chance to Prevent Type 2 Diabetes, https://www.cdc.gov/diabetes/basics/prediabetes.html. 2. American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care 2018 Mar. <http://www.diabetes.org/advocacy/news-events/cost-of- diabetes.html>.
29.
30Copyright © 2019
23andMe, Inc. Early Diagnosis and Prevention ● When high blood sugar is identified early, it's possible to delay and even prevent the progression of prediabetes to diabetes.1 ● If you are overweight and prediabetic, losing 5-7% of your body weight can reduce your likelihood of developing type 2 diabetes by up to half.1 ● Type 2 diabetes is one of the most-requested reports from our customers. ● Roughly one million of our current customers may learn of an increased likelihood ● We want to raise awareness about the importance of healthy lifestyle in type 2 diabetes prevention and how to reduce your likelihood of developing the condition. 1. The Centers for Disease Control and Prevention. “Prediabetes: Your Chance to Prevent Type 2 Diabetes.” <https://www.cdc.gov/diabetes/basics/prediabetes.html>.
30.
31Copyright © 2019
23andMe, Inc. 2.5M GWAS of consented participants 90%don’t know they have it 1,200+ genetic variants influencing T2D identified Report Powered by 23andMe Data
31.
32Copyright © 2019
23andMe, Inc. 23andMe GWAS Results Capture Same Variants of External GWAS Dataset (Scott et al. 2017)
32.
33Copyright © 2019
23andMe, Inc. Type 2 Diabetes Polygenic Score Performance Overall Polygenic Score Performance >6x increase in diabetes prevalence from bottom of Polygenic Score to top. Group T2D Odds Ratio (top 5% versus average) European 3.15 Latino 2.82 East Asian 2.22 South Asian 2.13 African American 1.91 Performance Across Ethnicities Polygenic Score ventiles
33.
34Copyright © 2019
23andMe, Inc. Effect Sizes are Concordant between Studies and 23andMe GWAS Has More Power 23andMe GWAS Scott et al. 2017 GWAS Number of Cases 77,000 27,000 Number of Controls 1,400,000 130,000
34.
35Copyright © 2019
23andMe, Inc. 23andMe Type 2 Diabetes Report
35.
Confidential Information -
Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reservedConfidential Information - Do Not Distribute Copyright © 2019 23andMe, Inc. All rights reserved Do Results Impact Behavior? 36
36.
37Copyright © 2017
23andMe, Inc. All rights reserved. The Saturated Fat and Weight Report Result 2 (Genotype at rs5082: GG)Result 1 (Genotype at rs5082: AA/AG) If we give customers this information, will they change their dietary behaviors?
37.
38Copyright © 2017
23andMe, Inc. All rights reserved. Genetic results can trigger behavior change 49% Yes 51% No At six months, any self-reported dietary change since viewing the report n = 8192 Report had an impact on decision to make dietary changes 33% No 67% Yes A survey taken six months post-result viewing showed sustained behavior change
38.
39Copyright © 2017
23andMe, Inc. All rights reserved. Genetic results can trigger behavior change Are you still maintaining this change to foods high in unsaturated fats? Are you still maintaining this change to foods high in saturated fats? 3% No 9% No 97% Yes 91% Yes
39.
40Copyright © 2017
23andMe, Inc. All rights reserved. A prevention hypothesis Data Prediction Action Prevention Risk models (genetic + non-genetic) Interventional studies Long-term follow up
Download now